20 ML acyclovir 50 MG/ML Injection — RxCUI 1734934
RxNorm drug concept · Semantic clinical drug
RxCUI 1734934
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
15 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1734934
Official name20 ML acyclovir 50 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asacyclovir 1000 MG per 20 ML Injection; acyclovir sodium 1000 MG in 20 ML Injection; 20 ML acycycloguanosine 50 MG/ML Injection; acyclovir 50 MG/ML (equivalent to acyclovir sodium 54.9 MG/ML) per 20 ML Injection
FDA products mapped13
Package NDCs mapped15
Reported Medicaid activity (SDUD)644 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acyclovir Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Acyclovir cream is used to treat cold sores — those small, painful blisters that appear on or around the lips, caused by the herpes simplex virus. It's approved for adults and teen...
- What exactly is acyclovir cream used for?
- The sooner the better — ideally at the very first tingle or sign of a cold sore coming on. For the ointment form, the standard schedule is every 3 hours, 6 times a day, for 7 days....
- When should I start applying it, and how often?
🕸️ Concept Web — How 20 ML acyclovir 50 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
20 ML acyclovir 50 MG/ML Injection
RxCUI 1734934 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Acyclovir
281IN
-
Acyclovir
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acyclovir Injection
1734931SCDF -
Acyclovir Injectable Product
1153458SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Acyclovir Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acyclovir 50 MG/ML
343725SCDC
-
Acyclovir 50 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acyclovir 50 MG/ML
SCDC · 343725 -
Acyclovir Injection
SCDF · 1734931 -
Acyclovir Injectable Product
SCDG · 1153458
📦 FDA Products & Package NDCs
13 products · 15 package NDCs
15 package NDCs map to RxCUI 1734934 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 55150-0154-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-154-10) / 10 mL in... | Acyclovir Sodium | Eugia US LLC | 2013-10-11 |
| 55150-0154-11 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-154-11) / 10 mL in... | Acyclovir Sodium | AuroMedics Pharma LLC | 2013-10-11 |
| 55150-0155-20 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-155-20) / 20 mL in... | Acyclovir Sodium | Eugia US LLC | 2013-10-11 |
| 55150-0155-21 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-155-21) / 20 mL in... | Acyclovir Sodium | AuroMedics Pharma LLC | 2013-10-11 |
| 63323-0325-10 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-10) / 10 mL in 1... | Acyclovir | Fresenius Kabi USA, LLC | 2000-10-17 |
| 63323-0325-14 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-14) / 10 mL in 1... | Acyclovir | Fresenius Kabi USA, LLC | 2000-10-17 |
| 63323-0325-20 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-20) / 20 mL in 1... | Acyclovir | Fresenius Kabi USA, LLC | 2000-10-17 |
| 63323-0325-24 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-24) / 20 mL in 1... | Acyclovir | Fresenius Kabi USA, LLC | 2000-10-17 |
| 65219-0622-10 | 10 VIAL in 1 CARTON (65219-622-10) / 10 mL in 1 VIAL (65219... | acyclovir | Fresenius Kabi USA, LLC | 2024-12-16 |
| 65219-0624-20 | 10 VIAL in 1 CARTON (65219-624-20) / 20 mL in 1 VIAL (65219... | acyclovir | Fresenius Kabi USA, LLC | 2024-12-16 |
| 68382-0048-10 | 10 VIAL, SINGLE-USE in 1 CARTON (68382-048-10) / 10 mL in 1... | acyclovir | Zydus Pharmaceuticals (USA) Inc. | 2018-11-27 |
| 68382-0049-10 | 10 VIAL, SINGLE-USE in 1 CARTON (68382-049-10) / 20 mL in 1... | acyclovir | Zydus Pharmaceuticals (USA) Inc. | 2018-11-27 |
| 70771-1383-06 | 10 VIAL, SINGLE-USE in 1 CARTON (70771-1383-6) / 10 mL in 1... | acyclovir | Zydus Lifesciences Limited | 2018-11-27 |
| 70771-1384-06 | 10 VIAL, SINGLE-USE in 1 CARTON (70771-1384-6) / 20 mL in 1... | acyclovir | Zydus Lifesciences Limited | 2018-11-27 |
| 84549-0155-20 | 20 mL in 1 VIAL, SINGLE-DOSE (84549-155-20) | Acyclovir Sodium | ProPharma Distribution | 2025-08-27 |
Observed labelers:
Fresenius Kabi USA, LLC (6) ·
AuroMedics Pharma LLC (4) ·
Eugia US LLC (4) ·
Zydus Lifesciences Limited (2) ·
Zydus Pharmaceuticals (USA) Inc. (2) ·
ProPharma Distribution (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0133 | Acyclovir injection | 8 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.